Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

iShares Genomics Immunology and Healthcare ETF (IDNA) Short Interest Ratio & Short Volume

iShares Genomics Immunology and Healthcare ETF logo
$29.45 0.00 (0.00%)
As of 05/22/2026 04:10 PM Eastern
Compare

iShares Genomics Immunology and Healthcare ETF Short Interest Overview

As of April 30, 2026, iShares Genomics Immunology and Healthcare ETF (IDNA) had a short interest of 47,511 shares sold short, representing 0.87% of the public float. This marks a -61.41% decrease in short interest since the prior report. The short interest ratio (days to cover) is 0.9, meaning it would take 0.9 days of the average trading volume of 40,915 shares to cover all short positions.

Current Short Interest
47,511 shares
Previous Short Interest
123,125 shares
Change Vs. Previous Month
-61.41%
Dollar Volume Sold Short
$1.40 million
Short Interest Ratio
0.9 Days to Cover
Last Record Date
April 30, 2026
Outstanding Shares
5,450,000 shares
Short Percent of Float
0.87%
Today's Trading Volume
18,751 shares
Average Trading Volume
40,915 shares
Today's Volume Vs. Average
46%
Short Selling iShares Genomics Immunology and Healthcare ETF?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for iShares Genomics Immunology and Healthcare ETF and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

IDNA Short Interest Over Time

IDNA Days to Cover Over Time

IDNA Percentage of Float Shorted Over Time

iShares Genomics Immunology and Healthcare ETF Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202647,511 shares $1.40 million -61.4%0.9%0.86 $29.39
4/15/2026123,125 shares $3.81 million +149.4%2.3%4.05 $30.97
3/31/202649,366 shares $1.43 million +9.5%0.9%1.91 $29.05
3/13/202645,077 shares $1.30 million -36.4%0.9%1.15 $28.78
2/27/202670,842 shares $2.21 million +113.7%1.4%2.57 $31.13
2/13/202633,149 shares $963.31 thousand +277.5%0.7%0.69 $29.06
1/30/20268,781 shares $250.35 thousand +30.2%0.2%0.17 $28.51
1/15/20266,747 shares $190.20 thousand +428.4%0.1%0.17 $28.19
12/31/20251,277 shares $33.44 thousand -86.6%0.0%0.07 $26.19
12/15/20259,491 shares $251.51 thousand -82.8%0.2%0.37 $26.50
11/28/202555,051 shares $1.52 million +797.9%1.1%2.08 $27.55
11/14/20256,131 shares $160.08 thousand +90.7%0.1%0.24 $26.11
10/31/20253,215 shares $81.50 thousand -83.2%0.1%0.07 $25.35
10/15/202519,200 shares $480.96 thousand -49.7%0.4%0.8 $25.05
9/30/202538,200 shares $901.90 thousand +36.4%N/A1.5 $23.61
9/15/202528,000 shares $631.40 thousand -26.5%N/A1.2 $22.55
8/31/202538,100 shares $844.30 thousand +370.4%0.7%1.5 $22.16
8/15/20258,100 shares $185.33 thousand +237.5%N/A0.3 $22.88
7/31/20252,400 shares $51 thousand -41.5%0.0%0.1 $21.25
7/15/20254,100 shares $85.81 thousand -37.9%N/A0.1 $20.93
6/30/20256,600 shares $135.37 thousand +43.5%0.1%0.2 $20.51
6/15/20254,600 shares $97.34 thousand -31.3%0.1%0.2 $21.16
5/31/20256,700 shares $134.74 thousand -4.3%0.1%0.2 $20.11
5/15/20257,000 shares $136.57 thousand +29.6%N/A0.2 $19.51
4/30/20255,400 shares $113.51 thousand +107.7%N/A0.2 $21.02
4/15/20252,600 shares $50.60 thousand -80.7%N/A0.1 $19.46
3/14/202513,600 shares $298.52 thousand +130.5%N/A0.4 $21.95
2/14/20252,900 shares $66.44 thousand +123.1%N/A0.1 $22.91
1/31/20251,300 shares $29.64 thousand -89.0%N/A0 $22.80
1/15/202511,800 shares $258.66 thousand -28.1%N/A0.3 $21.92

IDNA Short Interest - Frequently Asked Questions

Short interest is the volume of iShares Genomics Immunology and Healthcare ETF shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 47,511 shares of IDNA short. 0.87% of iShares Genomics Immunology and Healthcare ETF's shares are currently sold short. Learn More on iShares Genomics Immunology and Healthcare ETF's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDNA shares currently have a short interest ratio of 0.9. Learn More on iShares Genomics Immunology and Healthcare ETF's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.87% of iShares Genomics Immunology and Healthcare ETF's floating shares are currently sold short.

iShares Genomics Immunology and Healthcare ETF saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 47,511 shares, a decline of 61.4% from the previous total of 123,125 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.87% of iShares Genomics Immunology and Healthcare ETF's shares are currently sold short. Here is how the short interest of companies compare to iShares Genomics Immunology and Healthcare ETF: Inspire Faithward Mid Cap Momentum ETF (0.76%), Stance Sustainable Beta ETF (0.22%), Matthews Asia Innovators Active ETF (0.41%), iShares MSCI Agriculture Producers ETF (0.46%), iShares Self-Driving EV and Tech ETF (0.95%), iShares ESG Advanced MSCI EM ETF (0.92%), Amplify Digital Payments ETF (0.71%), American Conservative Values ETF (0.71%), VanEck Low Carbon Energy ETF (0.07%), Invesco MSCI Sustainable Future ETF (0.01%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling IDNA is an investing strategy that aims to generate trading profit from iShares Genomics Immunology and Healthcare ETF as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares Genomics Immunology and Healthcare ETF occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDNA, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDNA, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like IDNA:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (NYSEARCA:IDNA) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
SpaceX will mint billionaires. You won't be one of them.
By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...
Behind the Markets | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel